The patent EP3664798 was granted to Amneal Pharmaceuticals on Jun 17, 2020. The application was originally filed on Aug 6, 2018 under application number EP18845286A. The patent is currently recorded with a legal status of "Intended To Grant".

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents